Joohyun Hong
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
A single-arm phase II trial of UGT1A1 genotype-guided high-dose irinotecan rechallenge in refractory metastatic colorectal cancer.
Journal: Frontiers in oncology
Published: June 12, 2026
Multicenter single-arm phase II trial of lenvatinib in patients with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab.
Journal: Journal of hepatology
Published: May 10, 2025
Breast cancers with neuroendocrine differentiation: Retrospective case studies series from a single institution based on the 2019 WHO classification.
Journal: Cancer treatment and research communications
Published: July 30, 2024
Tumor mutation burden in gastro-entero-pancreatic-neuroendocrine neoplasms.
Journal: Journal of gastrointestinal oncology
Published: November 23, 2022
Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder.
Journal: Cancer research and treatment
Published: May 30, 2022
A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma.
Journal: Frontiers in oncology
Published: February 12, 2022
Perioperative HER2 targeted treatment in early stage HER2-positive breast cancer.
Journal: Therapeutic advances in medical oncology
Published: January 07, 2022
Osimertinib Combined with Systemic Chemotherapy for EGFR Mutant, T790M-Negative, Non-Small Cell Lung Cancer Patients Who Develop Leptomeningeal Metastases with Extracranial Progression to Prior EGFR TKI.
Journal: Cancer research and treatment
Published: December 24, 2021
Expression of PD-L1 as a predictive marker of sensitivity to immune checkpoint inhibitors in patients with advanced biliary tract cancer.
Journal: Therapeutic advances in gastroenterology
Published: December 15, 2021
Last Updated: 09/26/2026